Pfizer (PFE) Holder Payden & Rygel Has Lowered Stake; Orrstown Financial Services Cut Its Position in Duke Energy New Com New (DUK) by $348,864

Pfizer Inc. (NYSE:PFE) Logo

Orrstown Financial Services Inc decreased its stake in Duke Energy Corp New Com New (DUK) by 75.38% based on its latest 2018Q3 regulatory filing with the SEC. Orrstown Financial Services Inc sold 4,416 shares as the company’s stock rose 9.96% while stock markets declined. The institutional investor held 1,442 shares of the power generation company at the end of 2018Q3, valued at $115,000, down from 5,858 at the end of the previous reported quarter. Orrstown Financial Services Inc who had been investing in Duke Energy Corp New Com New for a number of months, seems to be less bullish one the $60.45 billion market cap company. The stock decreased 0.55% or $0.47 during the last trading session, reaching $84.8. About 95,819 shares traded. Duke Energy Corporation (NYSE:DUK) has risen 2.97% since January 11, 2018 and is uptrending. It has outperformed by 2.97% the S&P500. Some Historical DUK News: 07/05/2018 – Duke Energy helps South Carolina customers go solar with more than $50 million in rebates; 08/05/2018 – Duke Energy Corp expected to post earnings of $1.14 a share – Earnings Preview; 16/04/2018 – DUKE ENERGY’S $62M SOLAR REBATE PROGRAM APPROVED FOR NORTH CARO; 29/05/2018 – NCUC approves Piedmont Natural Gas request to decrease rates for the fourth time in 2018; 16/05/2018 – Duke Energy at American Gas Association Financial Forum May 20; 13/04/2018 – Duke Energy Ohio asks the Ohio Power Siting Board to move forward with its consideration of the Central Corridor Pipeline application; 10/05/2018 – DUKE HAS $2B EQUITY ISSUE TARGET IN 2018; 21/05/2018 – DUKE RAISES OCONEE 3 REACTOR TO 100% POWER FROM 0% FRIDAY: NRC; 06/03/2018 – Duke Energy Announces Public Offering of Common Stk With a Forward Component; 11/05/2018 – DUKE CUTS CATAWBA 2 REACTOR TO 65% POWER FROM 100%: NRC

Payden & Rygel decreased its stake in Pfizer (PFE) by 2.35% based on its latest 2018Q3 regulatory filing with the SEC. Payden & Rygel sold 17,420 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 724,970 shares of the health care company at the end of 2018Q3, valued at $31.95M, down from 742,390 at the end of the previous reported quarter. Payden & Rygel who had been investing in Pfizer for a number of months, seems to be less bullish one the $244.57B market cap company. The stock 0.02% or $0 during the last trading session, reaching $42.31. It is down 25.07% since January 11, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 27/03/2018 – GlaxoSmithKline last week quit the race to buy Pfizer’s consumer healthcare business, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion; 23/03/2018 – GLAXOSMITHKLINE PLC GSK.L – CONFIRMS IT HAS WITHDRAWN FROM PROCESS RELATING TO PFIZER’S CONSUMER HEALTHCARE BUSINESS; 30/05/2018 – TNF Cycling in Psoriatic Arthritis Declines for the Second Year in a Row as Newly Approved Agents Such as Pfizer’s Xeljanz and Eli Lilly’s Taltz Claim Their Share of the Switching Population; 18/05/2018 – U.S. FDA SAYS THERE WAS NO CHANGE IN THE ADVERSE EVENT PROFILE OF KEYTRUDA OR TECENTRIQ; 10/04/2018 – Pfizer: Primary Endpoint Was Extending Disease-Free Survival Compared With Placebo; 03/04/2018 – RT @CNBCnow: NEW: Pfizer in talks with P&G on the sale of its consumer business, but the companies are far apart on price, sources tell @Da…; 17/05/2018 – LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint; 10/04/2018 – PFIZER INC – WILL CONDUCT ADDITIONAL ANALYSES ON DATA FROM AXITINIB STUDY; 30/05/2018 – Pfizer’s Xeljanz Gets Expanded FDA Approval for Adults With Moderately to Severely Active Ulcerative Colitis; 29/05/2018 – Phase lll lMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to…

More notable recent Duke Energy Corporation (NYSE:DUK) news were published by: Seekingalpha.com which released: “Duke Energy downgraded at BAML on valuation, Atlantic Coast pipeline risks – Seeking Alpha” on January 09, 2019, also Fool.com with their article: “Forget Duke Energy Corporation — Brookfield Infrastructure Partners Is a Better Dividend Growth Stock – The Motley Fool” published on December 30, 2018, Seekingalpha.com published: “Duke Energy Corporation: This 5.625% Baby Bond Has Begun Trading On The NYSE – Seeking Alpha” on September 24, 2018. More interesting news about Duke Energy Corporation (NYSE:DUK) were released by: Bizjournals.com and their article: “Court puts up new roadblock for Duke Energy’s Atlantic Coast Pipeline – Charlotte Business Journal” published on December 14, 2018 as well as Gurufocus.com‘s news article titled: “Duke Energy energized Florida communities with more than $3 million in grants, 20000 volunteer hours in 2018 – GuruFocus.com” with publication date: January 10, 2019.

Investors sentiment decreased to 0.91 in 2018 Q3. Its down 0.04, from 0.95 in 2018Q2. It fall, as 46 investors sold DUK shares while 386 reduced holdings. 79 funds opened positions while 312 raised stakes. 408.54 million shares or 94.96% less from 8.11 billion shares in 2018Q2 were reported. Hbk Sorce Advisory Limited Co, a Pennsylvania-based fund reported 8,412 shares. Baldwin Brothers Ma stated it has 33 shares or 0% of all its holdings. National Bank & Trust Of Nova Scotia reported 0.04% of its portfolio in Duke Energy Corporation (NYSE:DUK). Asset invested 0.09% of its portfolio in Duke Energy Corporation (NYSE:DUK). Aqr Capital Mngmt Ltd Com has 0.07% invested in Duke Energy Corporation (NYSE:DUK). The Texas-based Linscomb & Williams has invested 0.38% in Duke Energy Corporation (NYSE:DUK). Mutual Of Omaha Bancorporation Wealth has 0.12% invested in Duke Energy Corporation (NYSE:DUK). Colonial Tru Advisors holds 129,336 shares or 1.94% of its portfolio. Lee Danner Bass Incorporated accumulated 43,794 shares. Eii Cap Mgmt holds 899 shares. 225,108 are held by Qs Invsts Limited Liability. Finemark State Bank Trust holds 0.45% in Duke Energy Corporation (NYSE:DUK) or 91,977 shares. Coastline Trust holds 0.04% or 3,905 shares in its portfolio. Florida-based Gyroscope Cap Mgmt Gru Lc has invested 0.16% in Duke Energy Corporation (NYSE:DUK). Canandaigua Bankshares And Tru accumulated 21,580 shares.

Analysts await Duke Energy Corporation (NYSE:DUK) to report earnings on February, 19. They expect $0.91 EPS, down 3.19% or $0.03 from last year’s $0.94 per share. DUK’s profit will be $648.72M for 23.30 P/E if the $0.91 EPS becomes a reality. After $1.65 actual EPS reported by Duke Energy Corporation for the previous quarter, Wall Street now forecasts -44.85% negative EPS growth.

Among 20 analysts covering Duke Energy (NYSE:DUK), 6 have Buy rating, 2 Sell and 12 Hold. Therefore 30% are positive. Duke Energy had 103 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Citigroup with “Sell” on Tuesday, October 17. As per Monday, July 23, the company rating was upgraded by JP Morgan. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, December 13. The rating was downgraded by Argus Research on Wednesday, April 6 to “Hold”. The stock of Duke Energy Corporation (NYSE:DUK) earned “Hold” rating by SunTrust on Monday, February 26. On Friday, January 8 the stock rating was maintained by Argus Research with “Buy”. The company was maintained on Thursday, March 8 by Morgan Stanley. On Friday, February 19 the stock rating was downgraded by JP Morgan to “Neutral”. The firm has “Buy” rating by UBS given on Monday, February 22. The stock has “Neutral” rating by Suntrust Robinson on Monday, October 19.

Since July 20, 2018, it had 0 insider buys, and 2 sales for $1.92 million activity. SUSMAN SALLY had sold 40,381 shares worth $1.50M.

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Cardinal Cap Mgmt holds 0.08% or 18,000 shares in its portfolio. Evercore Wealth Mngmt Limited Liability Com holds 0.48% in Pfizer Inc. (NYSE:PFE) or 342,239 shares. Millennium Mgmt Limited Com has invested 0.01% of its portfolio in Pfizer Inc. (NYSE:PFE). Court Place Advsrs Limited Liability Company has invested 1.37% in Pfizer Inc. (NYSE:PFE). Advsr Lc has invested 1.14% in Pfizer Inc. (NYSE:PFE). Chemung Canal Tru invested in 225,294 shares. Lvm Capital Management Mi has invested 0.94% in Pfizer Inc. (NYSE:PFE). Family Tru reported 7,200 shares or 0.13% of all its holdings. Moreover, Gemmer Asset Mngmt Ltd Liability Company has 0.39% invested in Pfizer Inc. (NYSE:PFE) for 28,515 shares. Cincinnati Casualty holds 236,400 shares or 8.58% of its portfolio. 347,497 were accumulated by Cadence Capital Ltd Company. Headinvest Limited Liability Company owns 30,060 shares. Ontario – Canada-based Cibc Ww has invested 0.46% in Pfizer Inc. (NYSE:PFE). Bahl & Gaynor reported 2.01M shares. First Bankshares Of Mount Dora Tru Inv reported 2.42% of its portfolio in Pfizer Inc. (NYSE:PFE).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 29 before the open. They expect $0.64 EPS, up 3.23% or $0.02 from last year’s $0.62 per share. PFE’s profit will be $3.70 billion for 16.53 P/E if the $0.64 EPS becomes a reality. After $0.78 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -17.95% negative EPS growth.

Among 23 analysts covering Pfizer (NYSE:PFE), 8 have Buy rating, 1 Sell and 14 Hold. Therefore 35% are positive. Pfizer had 89 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was initiated by Cantor Fitzgerald with “Buy” on Thursday, June 7. The stock has “Neutral” rating by Societe Generale on Friday, March 24. On Monday, October 16 the stock rating was maintained by SunTrust with “Hold”. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Cowen & Co on Monday, August 14. BMO Capital Markets maintained it with “Buy” rating and $39.0 target in Tuesday, November 21 report. The stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by Jefferies on Wednesday, August 16. Morgan Stanley upgraded Pfizer Inc. (NYSE:PFE) rating on Friday, October 2. Morgan Stanley has “Overweight” rating and $38 target. The firm earned “Buy” rating on Wednesday, November 1 by UBS. As per Tuesday, May 16, the company rating was downgraded by Citigroup. The firm earned “Buy” rating on Thursday, April 7 by Jefferies.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart